DTIL Reports $1.2B Revenue, $0.15 EPS, +45% YoY; Announces PBGENE-HBV cccDNA Elimination Data at EASL 2026; Investor Webcast Today
Precision BioSciences, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $7.02
-13% in 1d after detection
Post-detection moves
1h
+7.2%
1d
-13%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS